News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Deals
Eyetech Pharmaceuticals Will Be Closely Watched
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
In the sagging market for biotechnology-company IPOs, all eyes are on Eyetech Pharmaceuticals Inc.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Podcast
A Conversation With Kevin Marks, CEO of Delphia
March 4, 2025
·
1 min read
·
Annalee Armstrong
Deals
BridgeBio Oncology Takes Unexpected SPAC Track to Public Markets in $450M Deal
February 28, 2025
·
2 min read
·
Annalee Armstrong
Business
Money Meets Medicine: A Disruptor’s Guide to Life Sciences Investment
February 27, 2025
·
1 min read
·
Lori Ellis
Editorial
The
BioSpace
Book Club Investigates the Biggest Deals of All Time
February 26, 2025
·
3 min read
·
Annalee Armstrong
